Literature DB >> 10607679

The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype.

B K Singleton1, C A Green, N D Avent, P G Martin, E Smart, A Daka, E G Narter-Olaga, L M Hawthorne, G Daniels.   

Abstract

Antigens of the Rh blood group system are encoded by 2 homologous genes, RHD and RHCE, that produce 2 red cell membrane proteins. The D-negative phenotype is considered to result, almost invariably, from homozygosity for a complete deletion of RHD. The basis of all PCR tests for predicting fetal D phenotype from DNA obtained from amniocytes or maternal plasma is detection of the presence of RHD. These tests are used in order to ascertain the risk of hemolytic disease of the newborn. We have identified an RHD pseudogene (RHD psi) in Rh D-negative Africans. RHDpsi contains a 37 base pair (bp) insert in exon 4, which may introduce a stop codon at position 210. The insert is a sequence duplication across the boundary of intron 3 and exon 4. RHDpsi contains another stop codon in exon 6. The frequency of RHDpsi in black South Africans is approximately 0.0714. Of 82 D-negative black Africans, 66% had RHDpsi, 15% had the RHD-CE-D hybrid gene associated with the VS+ V- phenotype, and only 18% completely lacked RHD. RHDpsi is present in about 24% of D-negative African Americans and 17% of D-negative South Africans of mixed race. No RHD transcript could be detected in D-negative individuals with RHDpsi, probably as a result of nonsense-mediated mRNA decay. Existing PCR-based methods for predicting D phenotype from DNA are not suitable for testing Africans or any population containing a substantial proportion of people with African ethnicity. Consequently, we have developed a new test that detects the 37 bp insert in exon 4 of RHDpsi. (Blood. 2000; 95:12-18)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10607679

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  56 in total

Review 1.  Molecular genetics and clinical applications for RH.

Authors:  Willy A Flegel
Journal:  Transfus Apher Sci       Date:  2011-01-28       Impact factor: 1.764

2.  Blood group genotyping facilitates transfusion of beta-thalassemia patients.

Authors:  Lilian Castilho; Maria Rios; Jordão Pellegrino; Sara T O Saad; Fernando F Costa
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

3.  Non-invasive foetal RHD genotyping in transfusion medicine.

Authors:  Gregory A Denomme
Journal:  Blood Transfus       Date:  2011-11-16       Impact factor: 3.443

4.  Implementing non-invasive RHD genotyping on cell-free foetal DNA from maternal plasma: the Pavia experience.

Authors:  Ilaria Sbarsi; Paola Isernia; Laura Montanari; Carla Badulli; Miryam Martinetti; Laura Salvaneschi
Journal:  Blood Transfus       Date:  2011-11-16       Impact factor: 3.443

5.  RHD allelic identification among D-Brazilian blood donors as a routine test using pools of DNA.

Authors:  Mariza Mota; M Dezan; M C Valgueiro; A M Sakashita; J M Kutner; L Castilho
Journal:  J Clin Lab Anal       Date:  2012-02       Impact factor: 2.352

6.  Benefits of blood group genotyping in multi-transfused patients from the south of Brazil.

Authors:  Gláucia Andréia Soares Guelsin; Ana Maria Sell; Lilian Castilho; Viviane Lika Masaki; Fabiano Cavalcante Melo; Margareth Naomi Hashimoto; Tatiana Takahashi Higa; Loide Souza Hirle; Jeane Eliete Laguila Visentainer
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

7.  Applications and Experience with PCR-Based Assays to Predict Blood Group Antigens.

Authors:  Marion E Reid
Journal:  Transfus Med Hemother       Date:  2009-06       Impact factor: 3.747

8.  It is worthwhile filling in the remaining blank spots for blood group antigen frequencies.

Authors:  Christof Weinstock
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

9.  The JAL antigen (RH48) is the result of a change in RHCE that encodes Arg114Trp.

Authors:  Connie M Westhoff; Sunitha Vege; Dwane Wylie; Pam Nickle; Christine Lomas-Francis; Kim Hue-Roye; Marion E Reid
Journal:  Transfusion       Date:  2008-12-23       Impact factor: 3.157

10.  DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications.

Authors:  Connie M Westhoff; Sunitha Vege; Christine Halter-Hipsky; Trina Whorley; Kim Hue-Roye; Christine Lomas-Francis; Marion E Reid
Journal:  Transfusion       Date:  2010-01-15       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.